Measured by its ability to inhibit FGF acidic (170431) dependent proliferation of Balb/c3T3 mouse embryonic fibroblasts. The ED50 for this effect is typically 30.11 ng/mL in the presence of 80.0 ng/mL FGF acidic.
Measured by its ability to inhibit FGF acidic (170431) dependent proliferation of Balb/c3T3 mouse embryonic fibroblasts. The ED50 for this effect is typically 30.11 ng/mL in the presence of 80.0 ng/mL FGF acidic.
50.8-72.9 kDa, under reducing conditions; 46.4-64.1 kDa, under non-reducing conditions.
分子类型
蛋白质
产品线
生物产品
储存与运输
物理形态
冻干(Lyophilized)
储存缓冲液
Lyophilized from PBS, pH 7.4.
复溶
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute at 0.5 mg/mL in sterile distilled water. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
在 -20°C 下可保存 1 年。避免冷冻/解冻循环。
图片
Recombinant Human FGFR4 Protein (rp183620) - Protein Bioactivity Measured by its ability to inhibit FGF acidic (rp170431) dependent proliferation of Balb/c3T3 mouse embryonic fibroblasts. The ED₅₀ for this effect is typically 30.11 ng/mL in the presence of 80.0 ng/mL FGF acidic.
Recombinant Human FGFR4 Protein (rp183620) - SDS-PAGE 3 μg/lane of Recombinant Human FGFR4 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a band at 50.8-72.9 kDa under reducing conditions and 46.4-64.1 kDa under non-reducing conditions.
ZJ24F1012378
危险品化学品经营许可证（带存储）